<--- Back to Details
| First Page | Document Content | |
|---|---|---|
 Date: 2014-04-13 16:08:55Health Biotechnology Patent law Research exemption Generic drug Food and Drug Administration Abbreviated New Drug Application Drug Price Competition and Patent Term Restoration Act Declaratory judgment Approved Drug Products with Therapeutic Equivalence Evaluations Novartis |
Add to Reading List |
Microsoft Word - 10CV5118 Seattle Childrens Hosp v Akorn MTD.doc | Investigator Responsibilities in Protecting Participants in the Conduct of Bioequivalence Studies Cecilia C. Maramba, MD, MScIDDocID: 1ptht - View Document |
 | PUBLIC LAW 105–115—NOV. 21, 1997 FOOD AND DRUG ADMINISTRATION MODERIZATION ACT OF 1997 111 STAT. 2296DocID: 1pnIy - View Document |
 | Updating ANDA Labeling After the Marketing Application for the Reference Listed Drug Has Been Withdrawn Guidance for IndustryDocID: 1p93k - View Document |
 | Case 2:06-cvHAA-ES Document 71 FiledPage 1 of 45 PageID: 1673 NOT FOR PUBLICATION UNITED STATES DISTRICT COURTDocID: 1m2hg - View Document |
| Microsoft Word - 10CV5118 Seattle Childrens Hosp v Akorn MTD.docDocID: 1lmCl - View Document |